Clinical trial
Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum…
NCT00343317 · University of KwaZulu, Other · Completed
Key facts
| NCT number | NCT00343317 |
|---|---|
| Title | Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women |
| Official title | Prophylactic Intrapartum Antibiotics and Immunological Markers for Postpartum Morbidity in HIV Positive Women |
| Lead sponsor | University of KwaZulu, Other |
| Collaborators | Bristol-Myers Squibb Industry |
| Status | Completed |
| Study type | Interventional |
| Conditions | Puerperal Sepsis |
| Intervention type | Drug |
| Interventions | Intrapartum Cefoxitin (2g) vs. placebo |
| Enrollment | 1,372 |
| Start date | Feb 1, 2003 |
| Completion | May 1, 2005 |
| First posted | Jun 22, 2006 |
| Last update posted | Jun 22, 2006 |
| Countries | South Africa |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: